These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 11850790)

  • 1. Oligonucleotide N3'-->P5' phosphoramidates as efficient telomerase inhibitors.
    Herbert BS; Pongracz K; Shay JW; Gryaznov SM
    Oncogene; 2002 Jan; 21(4):638-42. PubMed ID: 11850790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligonucleotide n3'-->p5' phosphoramidates and thio-phoshoramidates as potential therapeutic agents.
    Gryaznov SM
    Chem Biodivers; 2010 Mar; 7(3):477-93. PubMed ID: 20232321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligonucleotide N3' --> P5' thio-phosphoramidate telomerase template antagonists as potential anticancer agents.
    Gryaznov S; Asai A; Oshima Y; Yamamoto Y; Pongracz K; Pruzan R; Wunder E; Piatyszek M; Li S; Chin A; Harley C; Akinaga S; Yamashita Y
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):577-81. PubMed ID: 14565232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid modification of GRN163, an N3'-->P5' thio-phosphoramidate oligonucleotide, enhances the potency of telomerase inhibition.
    Herbert BS; Gellert GC; Hochreiter A; Pongracz K; Wright WE; Zielinska D; Chin AC; Harley CB; Shay JW; Gryaznov SM
    Oncogene; 2005 Aug; 24(33):5262-8. PubMed ID: 15940257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase inhibitors--oligonucleotide phosphoramidates as potential therapeutic agents.
    Gryaznov S; Pongracz K; Matray T; Schultz R; Pruzan R; Aimi J; Chin A; Harley C; Shea-Herbert B; Shay J; Oshima Y; Asai A; Yamashita Y
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):401-10. PubMed ID: 11563055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel telomerase template antagonist (GRN163) as a potential anticancer agent.
    Asai A; Oshima Y; Yamamoto Y; Uochi TA; Kusaka H; Akinaga S; Yamashita Y; Pongracz K; Pruzan R; Wunder E; Piatyszek M; Li S; Chin AC; Harley CB; Gryaznov S
    Cancer Res; 2003 Jul; 63(14):3931-9. PubMed ID: 12873987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase targeted oligonucleotide thio-phosphoramidates in T24-luc bladder cancer cells.
    Dikmen ZG; Wright WE; Shay JW; Gryaznov SM
    J Cell Biochem; 2008 May; 104(2):444-52. PubMed ID: 18044713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligonucleotide conjugate GRN163L targeting human telomerase as potential anticancer and antimetastatic agent.
    Gryaznov SM; Jackson S; Dikmen G; Harley C; Herbert BS; Wright WE; Shay JW
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1577-9. PubMed ID: 18066830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oligonucleotide N3'-->P5' thio-phosphoramidate (GRN163) targeting telomerase RNA in human multiple myeloma cells.
    Akiyama M; Hideshima T; Shammas MA; Hayashi T; Hamasaki M; Tai YT; Richardson P; Gryaznov S; Munshi NC; Anderson KC
    Cancer Res; 2003 Oct; 63(19):6187-94. PubMed ID: 14559802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a novel telomerase inhibitor, GRN163L, in human breast cancer.
    Gellert GC; Dikmen ZG; Wright WE; Gryaznov S; Shay JW
    Breast Cancer Res Treat; 2006 Mar; 96(1):73-81. PubMed ID: 16319992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel short oligonucleotide conjugates as inhibitors of human telomerase.
    Pongracz K; Li S; Herbert BS; Pruzan R; Wunder E; Chin A; Piatyszek M; Shay J; Gryaznov SM
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1627-9. PubMed ID: 14565482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor.
    Dikmen ZG; Gellert GC; Jackson S; Gryaznov S; Tressler R; Dogan P; Wright WE; Shay JW
    Cancer Res; 2005 Sep; 65(17):7866-73. PubMed ID: 16140956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiadhesive effects of GRN163L--an oligonucleotide N3'->P5' thio-phosphoramidate targeting telomerase.
    Jackson SR; Zhu CH; Paulson V; Watkins L; Dikmen ZG; Gryaznov SM; Wright WE; Shay JW
    Cancer Res; 2007 Feb; 67(3):1121-9. PubMed ID: 17283146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric inhibitors of telomerase: oligonucleotide N3'-->P5' phosphoramidates.
    Pruzan R; Pongracz K; Gietzen K; Wallweber G; Gryaznov S
    Nucleic Acids Res; 2002 Jan; 30(2):559-68. PubMed ID: 11788719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA mimetics: oligoribonucleotide N3'-->P5' phosphoramidates.
    Gryaznov SM; Winter H
    Nucleic Acids Res; 1998 Sep; 26(18):4160-7. PubMed ID: 9722635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
    Rankin AM; Faller DV; Spanjaard RA
    Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-Oligodeoxyribonucleotide N3'-->P5' phosphoramidates: synthesis and duplex formation.
    Pongracz K; Gryaznov SM
    Nucleic Acids Res; 1998 Feb; 26(4):1099-106. PubMed ID: 9461474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effects of specific telomerase inhibitor GRN163 in human glioblastoma xenografts.
    Ozawa T; Gryaznov SM; Hu LJ; Pongracz K; Santos RA; Bollen AW; Lamborn KR; Deen DF
    Neuro Oncol; 2004 Jul; 6(3):218-26. PubMed ID: 15279714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligonucleotide N3'-->P5' phosphoramidates as antisense agents.
    Gryaznov S; Skorski T; Cucco C; Nieborowska-Skorska M; Chiu CY; Lloyd D; Chen JK; Koziolkiewicz M; Calabretta B
    Nucleic Acids Res; 1996 Apr; 24(8):1508-14. PubMed ID: 8628685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
    Kelland LR
    Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.